MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
17.55
-0.84 (-4.57%)
At close: May 15, 2026, 4:00 PM EDT
17.56
+0.01 (0.06%)
Pre-market: May 18, 2026, 7:00 AM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $1.28 billion as of May 18, 2026. Its market cap has decreased by -51.39% in one year.
Market Cap
1.28B
Enterprise Value
1.02B
1-Year Change
-51.39%
Ranking
Category
Stock Price
$17.55
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.28B, an increase of 35,434.39%. That is a compound annual growth rate of 298.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.28B | 35.91% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 1.38B |
| GH Research | 1.38B |
| Biohaven | 1.36B |
| Bicara Therapeutics | 1.36B |
| Fortrea Holdings | 1.35B |
| AbCellera Biologics | 1.34B |
| Savara | 1.34B |
| MapLight Therapeutics | 1.33B |